Health Care

News Release | TexPIRG Education Fund | Health Care

Prices of common medications can vary by hundreds of dollars

While many Americans struggle to afford their prescription drugs, TexPIRG Education Fund’s survey of retail prices of commonly-prescribed medications found patients can save hundreds, even thousands of dollars in some cases by shopping around at pharmacies within their communities.

"Texans shouldn’t have to forgo life-saving medicines. But when they don't realize there are more affordable options at a different pharmacy, some have to do exactly that,” said Bay Scoggin, TexPIRG Education Fund’s Director.  “Our medications don’t work any better when we pay more for them. We need a transparent prescription drug system that delivers value to patients at a reasonable price, instead of confusing and price-gouging them."

Retail prescription drug spending represents about 10 percent of the overall national health expenditures in America, while nearly 1 in 4 Americans struggle to afford their prescription drugs primarily because of inflated prices.

TexPIRG Education Fund’s report, The Real Price of Medications: A Survey of Pharmaceutical Prices, released today, reveals a wide variation in the retail pricing of prescription drugs by pharmacies large and small, urban and rural. The report looked at prices in Dallas, El Paso, and Gainesville.

Report | TexPIRG Education Fund | Health Care

The Real Price of Medications

People living in the United States have access to some of the best medical care in the world, from life-saving drugs to cutting-edge surgical techniques. But our system is deeply flawed, with spiraling costs forcing many Americans to spend more on care and often receiving poor quality care for all the extra money spent.

Retail prescription drug costs represent about 10% of the total national healthcare expenditure in America and are a public concern because of existing high prices, which often continue to climb. In fact, nearly 1 in 4 Americans on medication struggle to afford their prescription drugs - and that rises to more than 4 in 10 for individuals in worse health.  Research on these high health care expenses (including prescription drug expenses) in comparison to other countries show that this difficult cost burden is driven primarily by inflated prices: not differences in the drugs used, our aging population, nor the amount of drugs prescribed.”

These high prices decimate the delivered value we get from medications. The main problem is this: although a patient may pay more for their life saving medicine, they are not getting any more health value for the extra money spent.

Research shows that high prices lead patients to engage in risky behaviors, including medication rationing or altering dosages without doctor’s consent. Nearly 17% of older adults exhibit this non-adherence behavior, the highest among 11 comparably wealthy countries. Physician treatment plans don’t work when patients can’t follow them, and research shows that medical treatment deviations account for major proportions of treatment failures and many hospital and nursing home admissions.

The picture is even more concerning when you consider that drug prices can vary greatly within cities, states and regions of the United States. Doctors may prescribe more expensive medication that is just as effective as other options, or patients may decide to forgo treatment, when more affordable options could be available at the pharmacy around the corner. Sometimes, the best treatment may be what the patient can consistently stick to, but with providers and patients unsure about prescription drug prices, that treatment decision becomes even more daunting.  
 

Right to Repair is a simple way to cut health care costs

By | Nathan Proctor
Director, Campaign for the Right to Repair

Cost containment is is a critical first step in addressing the deep faults in our health care system - it's hard to image fixing problems of access if we continue to be charged $15 for a Tylenol pill or $1,000 for a toothbrush. It turns out that overpriced equipment repair helps add to those inflated costs.

News Release | U.S. PIRG | Public Health, Consumer Protection, Health Care

Second recall of King Bio’s homeopathic drugs in the past month

King Bio Inc. issued the second significant voluntary recall since late July of their homeopathic drugs on Wednesday. Safety concerns over homeopathic drugs extend beyond King Bio as over the past several years, the FDA has issued recalls to several companies for a variety of health products from zinc-containing intranasal medicine to asthma drugs with toxic ingredients. 

News Release | Health Care

New health care executive order is a step in the wrong direction

Today, President Trump signed a new Executive Order that aims to loosen up rules for health insurance plans for individuals, families and small businesses. Though the administration touts the potential for lower-cost health insurance under looser rules, this action will not help American consumers. In fact, it is likely to make matters worse by destabilizing the markets Americans rely on for health coverage. American consumers need real action on health care costs, but this simply will not cut it.

California’s new drug price law is a win for consumers nationwide

Today, California Governor Jerry Brown signed Senate Bill 17 into law, a groundbreaking measure to increase transparency and accountability for the prescription drug industry. We celebrate the new law—passed with support and hard work from CALPIRG—as a landmark victory for consumers, not just in California, but nationwide.

News Release | Health Care

Our Statement in Opposition to Graham-Cassidy Health Care Bill

The latest version of health care legislation before the U.S. Senate remains very dangerous for American consumers, and we urge a “no” vote.

News Release | U.S. PIRG | Public Health, Health Care

Our Statement on the Failure of the US Senate Health Care Bill

American consumers can breathe a sigh of relief today. The legislation that was narrowly defeated in the US Senate last night threatened to spark chaos in health insurance markets, raise costs, degrade quality of care, weaken protections for people with pre-existing conditions, and cause millions of Americans to lose health coverage.

News Release | Health Care

Our Statement on Senate Health Care Bill

Statement by Jesse Ellis O’Brien, TexPIRG Health Care Advocate, on public release of the “Better Care Reconciliation Act.” 

News Release | Health Care

Great News for Consumers: Anthem Drops Bid to Take Over Cigna

This morning, health insurance giant Anthem dropped its troubled bid to take over one of its top competitors, Cigna. A February district court decision to block the proposed merger on anti-trust grounds was recently upheld by the DC Circuit Court of Appeals, but with Anthem’s decision today, this anti-competitive takeover bid is finally laid to rest. This development comes after months of work by TexPIRG and a broad coalition of consumer and health care groups, urging close scrutiny of the merger from state and federal regulators and raising questions and concerns about the potential impact on consumers.

Pages

Subscribe to RSS - Health Care

Support Us

Your donation supports TexPIRG's work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates, and take action on critical issues.
Optional Member Code